Clinical trial
Omission of Immediate Postoperative Radiation in Patients With Intermediate Pathological Risk Features and Negative Two-Week Post-Operative ctHPVDNA (OPERATION Trial)
NCT07513389 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Omission of Immediate Postoperative Radiation in Patients With Intermediate Pathological Risk Features and Negative Two-Week Post-Operative ctHPVDNA (OPERATION Trial)
- Lead sponsor
- Medical University of South Carolina
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- August 12, 2026
- Completion date
- July 1, 2034
- Enrollment
- 36 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
human papilloma virus (hpv), oropharyngeal squamous cell carcinoma (opscc), squamous cell carcinoma